Pituitary adenomas, although rare in the paediatric age range and mostly benign, represent very challenging disorders for diagnosis and management. The recent identification of genetic alterations in young individuals with pituitary adenomas has broadened the scope of molecular investigations and contributed to the understanding of mechanisms of tumorigenesis. Recent identification of causative mutations of genes such as GNAS, PRKAR1A, MEN1 and AIP has introduced the concept of molecular screening of young apparently healthy family members. Population-based studies have reported a significantly higher number of affected subjects and genetic variations than expected. Radiological techniques have advanced, yet many microadenomas remain undetectable on scanning. However, experience with transsphenoidal and endoscopic pituitary surgery has led to higher rates of cure. Prolactinomas, corticotroph and somatotroph adenomas remain the most prevalent, with each diagnosis presenting its own challenges. As paediatric pituitary adenomas occur very infrequently within the paediatric age range, paediatric endocrine units cannot provide expert management in isolation. Consequently, close co-operation with adult endocrinology colleagues with experience of pituitary disease is strongly recommended.

Keywords:
Paediatric pituitary adenoma, Cushing’s disease, Prolactinoma, Somatotroph adenoma, Gigantism
1.
Kunwar S, Wilson CB: Pediatric pituitary adenomas. J Clin Endocrinol Metab 1999;84:4385-4389.
2.
Jackman S, Diamond F: Pituitary adenomas in childhood and adolescence. Pediatr Endocrinol Rev 2013;10:450-459.
3.
Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gündogdu S, De Menis E, Mäkinen MJ, Launonen V, Karhu A, Aaltonen LA: Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006;312:1228-1230.
4.
Heliövaara E, Raitila A, Launonen V, Paetau A, Arola J, Lehtonen H, Sane T, Weil RJ, Vierimaa O, Salmela P, Tuppurainen K, Mäkinen M, Aaltonen LA, Karhu A: The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas. Am J Pathol 2009;175:2501-2507.
5.
Tichomirowa MA, Barlier A, Daly AF, Jaffrain-Rea ML, Ronchi C, Yaneva M, Urban JD, Petrossians P, Elenkova A, Tabarin A, Desailloud R, Maiter D, Schürmeyer T, Cozzi R, Theodoropoulou M, Sievers C, Bernabeu I, Naves LA, Chabre O, Montañana CF, Hana V, Halaby G, Delemer B, Aizpún JI, Sonnet E, Longás AF, Hagelstein MT, Caron P, Stalla GK, Bours V, Zacharieva S, Spada A, Brue T, Beckers A: High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol 2011;165:509-515.
6.
Steele CA, MacFarlane IA, Blair J, Cuthbertson DJ, Didi M, Mallucci C, Javadpour M, Daousi C: Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes. Eur J Endocrinol 2010;163:515-522.
7.
Lonser RR, Wind JJ, Niemann LK, Weil RJ, DeVroom HL, Oldfield EH: Outcome of surgical treatment of 200 children with Cushing's disease. J Clin Endocrinol Metab 2013;98:892-901.
8.
Keil MF, Stratakis CA: Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics. Expert Rev Neurother 2008;8:563-574.
9.
Xekouki P, Azevedo M, Stratakis CA: Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways. Expert Rev Endocrinol Metab 2010;5:697-709.
10.
Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M: Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab 2010;21:419-427.
11.
Volkl TM, Dorr HG: McCune-Albright syndrome: clinical picture and natural history in children and adolescents. J Pediatr Endocrinol Metab 2006;19(suppl 2):551-559.
12.
Stratakis CA, Tichomirowa MA, Boikos S, Azevedo MF, Lodish M, Martari M, Verma S, Daly AF, Raygada M, Keil MF, Papademetriou J, Drori-Herishanu L, Horvath A, Tsang KM, Nesterova M, Franklin S, Vanbellinghen JF, Bours V, Salvatori R, Beckers A: The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 2010;78:457-463.
13.
Vergès B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C, Calender A: Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002;87:457-465.
14.
Beckers A, Aaltonen LA, Daly AF, Karhu A: Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 2013;34:239-277.
15.
Lim EM, Pullan P, et al: Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. Clin Biochem Rev 2005;26:41-43.
16.
Kim EH, Oh MC, Kim SH: Application of low-field intraoperative magnetic resonance imaging in transsphenoidal surgery for pituitary adenomas: technical points to improve the visibility of the tumor resection margin. Acta Neurochir 2013;155:485-493.
17.
Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori WM: Diagnosis and treatment of hyperprolactinemia: an Endocrine Society practical guideline. J Clin Endocrinol Metab 2011;96:273:288.
18.
Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE: The prevalence of pituitary adenomas: a systematic review. Cancer 2004;101:613-619.
19.
Lucas JW, Zada G: Imaging of the pituitary and parasellar region. Semin Neurol 2012;32:320-331.
20.
Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M: Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2008;93:2454-2462.
21.
Storr HL, Drake WM, Evanson J, Matson M, Akker SA, Monson JP, Alusi G, Savage MO, Sabin HI: Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing's disease. Clin Endocrinol (Oxf) 2014;80:270-276.
22.
Personnier C, Cazabat L, Bertherat J, Gaillard S, Souberbielle JC, Habrand JL, Dufour C, Clauser E, SainteRose C, Polak M: Clinical features and treatment of pediatric somatotropinoma: case study of an aggressive tumor due to a new AIP mutation and extensive literature review. Horm Res Paed 2011;75:392-402.
23.
Goudakos JK, Markou KD, Georgalas C: Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis: Clin Otolaryngol 2011;36:212-220.
24.
DeKlotz TR, Chia SH, Lu W, Makambi KH, Aulisi E, Deeb Z: Meta-analysis of endoscopic versus sublabial pituitary surgery. Laryngoscope 2012;122:511-518.
25.
Massimi L, Rigante M, D'Angelo L, Paternoster G, Leonardi P, Paludetti G, Di Rocco C: Quality of postoperative course in children: endoscopic endonasal surgery versus sublabial microsurgery. Acta Neurochir (Wien) 2011;153:843-849.
26.
Chivukula S, Koutourousiou M, Snyderman CH, Fernandez-Miranda JC, Gardner PA, Tyler-Kabara EC: Endoscopic endonasal skull base surgery in the pediatric population. J Neurosurg Pediatr 2013;11:227-241.
27.
Hubina E, Nanzer AM, Hanson MR, Ciccarelli E, Losa M, Gaia D, Papotti M, Terreni MR, Khalaf S, Jordan S, Czirják S, Hanzély Z, Nagy GM, Góth MI, Grossman AB, Korbonits M: Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. Eur J Endocrinol 2006;155:371-379.
28.
Fideleff HL, Boquete HR, Suárez MG, Azaretzky M: Prolactinoma in children and adolescents. Horm Res 2009;72:197-205.
29.
Loeffler JS, Shih HA: Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab 2011;96:1992-2003.
30.
Sheehan JP, Xu Z, Lobo MJ: External beam radiation therapy and stereotactic radiosurgery for pituitary adenomas. Neurosurg Clin N Am 2012;23:571-586.
31.
Storr HL, Plowman PN, Carroll PV, François I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO: Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment. J Clin Endocrinol Metab 2003;88:34-37.
32.
Chan LF, Storr HL, Plowman PN, Perry LA, Besser GM, Grossman AB, Savage MO: Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy. Eur J Endocrinol 2007;156:477-482.
33.
Ciccarelli A, Daly AF, Beckers A: The epidemiology of prolactinomas. Pituitary 2005;8:3-6.
34.
Acharya SV, Gopal RA, Bandgar TR, Joshi SR, Menon PS, Shah NS: Clinical profile and long term follow up of children and adolescents with prolactinomas. Pituitary 2009;12:186-189.
35.
Eren E, Yapıcı Ş, Çakır ED, Ceylan LA, Sağlam H, Tarım Ö: Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases. J Clin Res Pediatr Endocrinol 2011;3:65-69.
36.
Colao AM, Loche S, Cappa M, Di Sarno A, Landi ML, Sarnacchiaro F, Faccioli G, Lombardi G: Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. J Clin Endocrinol Metab1998;83:2777-2780.
37.
Storr HL, Alexandraki KI, Martin L, Isidori AM, Kaltsas G, Monson JP, Besser GM, Matson M, Evanson J, Afshar F, Sabin I, Savage MO, Grossman AB: Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal therapy between paediatric and adult Cushing's disease. Eur J Endocrinol 2011;164:667-674.
38.
Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB, Nieman LK, Chrousos GP: Cushing's syndrome in children and adolescents, presentation, diagnosis and therapy. N Engl J Med 1994;331:629-636.
39.
Storr HL, Isidori AM, Monson JP, Besser GM, Grossman AB, Savage MO: Pre-pubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis. J Clin Endocrinol Metab 2004;89:3818-3820.
40.
Newell-Price J, Bertagna X, Grossman AB, Nieman LK: Cushing's syndrome. Lancet 2006;367:1605-1617.
41.
Batista DL, Oldfield EH, Keil MF, Stratakis CA: Postoperative testing to predict recurrent Cushing disease in children. J Clin Endocrinol Metab 2009;94:2757-2765.
42.
Cuny T, Pertuit M, Sahnoun-Fathallah M, Daly A, Occhi G, Odou MF, Tabarin A, Nunes ML, Delemer B, Rohmer V, Desailloud R, Kerlan V, Chabre O, Sadoul JL, Cogne M, Caron P, Cortet-Rudelli C, Lienhardt A, Raingeard I, Guedj AM, Brue T, Beckers A, Weryha G, Enjalbert A, Barlier A: Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis. Eur J Endocrinol 2013;168:533-541.
43.
Rix M, Hertel NT, Nielsen FC, Jacobsen BB, Hoejberg AS, Brixen K, Hangaard J, Kroustrup JP: Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1. Eur J Endocrinol 2004;151:709-715.
44.
Storr HL, Chan LF, Grossman AB, Savage MO: Paediatric Cushing's Disease: epidemiology, investigation and therapeutic advances. Trends Endocrinol Metab 2007;18:267-274.
45.
Acharya SV, Gopal RA, Goerge J, Menon PS, Bandgar TR, Shah NS: Radiotherapy in paediatric Cushing's disease: efficacy and long term follow up of pituitary function. Pituitary 2010;13:293-297.
46.
Thorén M, Rähn T, Hallengren B, Kaad PH, Nilsson KO, Ravn H, Ritzén M, Petersen KE, Aarskog D: Treatment of Cushing's disease in childhood and adolescence by stereotactic pituitary irradiation. Acta Paediatr Scand 1986;75:388-395.
47.
Barber TM, Adams E, Ansorge O, Byrne JV, Karavitaki N, Wass JA: Nelson's syndrome. Eur J Endocrinol 2010;163:495-507.
48.
Chan LF, Vaidya M, Westphal B, Allgrove J, Martin L, Afshar F, Hindmarsh PC, Savage MO, Grossman AB, Storr HL: Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease. Horm Res Paediatr 2011;75:441-446.
49.
Greening JE, Brain CE, Perry LA, Mushtaq I, Sales Marques J, Grossman AB, Savage MO: Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease. Horm Res 2005;64:140-143.
50.
Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira A Jr, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB, Korbonits M: The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 2008;93:2390-2401.
51.
Chahal HS, Trivellin G, Leontiou CA, Alband N, Fowkes RC, Tahir A, Igreja SC, Chapple JP, Jordan S, Lupp A, Schulz S, Ansorge O, Karavitaki N, Carlsen E, Wass JA, Grossman AB, Korbonits M: Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. J Clin Endocrinol Metab 2012;97:E1411-E1420.
52.
Andersen M: Management of endocrine disease: GH excess - diagnosis and medical therapy. Eur J Endocrinol 2013;170:R31-R41.
53.
Goldenberg N, Racine MS, Thomas P, Degnan B, Chandler W, Barkan A: Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant. J Clin Endocrinol Metab 2008;93:2953-2956.
54.
Yamaguchi-Okada M, Inoshita N, Nishioka H, Fukuhara N, Yamada S: Clinicopathological analysis of nonfunctioning pituitary adenomas in patients younger than 25 years of age. J Neurosurg Pediatr 2012;9:511-516.
55.
Rabbiosi S, Peroni E, Tronconi GM, Chiumello G, Losa M, Weber G: Asymptomatic thyrotropin-secreting pituitary macroadenoma in a 13-year old girl: successful first-line treatment with somatostatin analogs. Thyroid 2012;22:1076-1079.
56.
Kessler M, David R, Pawelczak M, Hanono A, Shah B: Thyrotropin-secreting pituitary adenoma in an adolescent boy: challenges in management. Pediatrics 2010;126:e474-e478.
57.
Clemente M, Caracseghi F, Gussinyer M, Yeste D, Albisu M, Vázquez E, Ortega A, Carrascosa A: Macroorchidism and panhypopituitarism: two different forms of presentation of FSH-secreting pituitary adenomas in adolescence. Horm Res Paediatr 2011;75:225-230.
58.
Batista DL, Riar J, Keil M, Stratakis CA: Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 2007;120:e575-e586.
59.
Shah NS, Lila A: Childhood Cushing disease: a challenge in diagnosis and management. Horm Res Paediatr 2011;76(suppl 1):65-70.
60.
Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM: The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008;93:1526-1540.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.